Details for Patent: 5,892,025
✉ Email this page to a colleague
Title: | Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers |
Abstract: | A process for the resolution of a racemic mixture of nucleoside enantiomers that includes the step of exposing the racemic mixture to an enzyme that referentially catalyzes a reaction in one of the enantiomers. The nucleoside enantiomer (-)-2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane is an effective antiviral agent against HIV, HBV, and other viruses replicating in a similar manner. |
Inventor(s): | Liotta; Dennis C. (McDonough, GA), Schinazi; Raymond F. (Decatur, GA), Choi; Woo-Baeg (North Brunswick, NJ) |
Assignee: | Emory University (Atlanta, GA) |
Filing Date: | Jul 14, 1998 |
Application Number: | |
Claims: | 1. A method for the resolution of the combination of enantiomers of cis-2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane comprising passing the cis-2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane through an acetylated .beta.-cyclodextrin chiral column and obtaining the (+) and (-) enantiomers of cis-2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane. |